⚒️ Ergon 全國專案數據平台 / 專案數據

Transformative Healthcare Instrument 2026

案件編號 9e7c73c8-19e9-4bbc-b374-b28a3170ae20
🤖 本頁數據由 Ergon AI 工作流(發現 → 真實瀏覽器採集 → 規格/AI 解析 → 附件加值)自動整理,僅供參考;申請資訊請以原始公告為準。

專案內容(AI 忠實提取,左)與原始公告頁(右)比對

Transformative Healthcare Instrument 2026

Apply now! Call open

Accelerate the growth of your healthcare start-up with the Transformative Healthcare Instrument.

EIT Health is offering between €300,000 and €500,000 in funding to support high-potential European start-ups developing innovative solutions in biotech, medtech, digital health, AI, and biomarkers or diagnostics. The programme is designed to help companies advance product development, strengthen commercialisation strategies, and prepare for their next stage of fundraising while addressing unmet clinical needs across Europe.

The call information and supporting documents are now available to help applicants prepare their proposals. Access to the application platform will open on 15 July 2026.

Who can apply?

The THI is intended to support private companies, specifically Micro, Small and Medium-sized enterprises (SMEs), with at least 4 full-time equivalent employees. Eligible companies must have closed a minimum total equity investment of 2,000,000 EUR within the previous 36-months, with at least one new investor contributing. Funded projects must be at the Innovation Maturity Levels (IML) listed below, depending on their industry focus:

  • IML ≥ 5 for Biotech (Safety/Toxicity study stage).
  • IML ≥ 6 in Medtech (Initial clinical PoC)
  • IML ≥ 7 for Digital (Market validation)
  • IML ≥ 7 for Biomarker / Diagnostics

Funding

Projects may request between 300,000 and 500,000 EUR in EIT Health funding. EIT Health will fund a maximum of 50% of the project’s total costs. The company must secure the remaining 50% co‑funding from other sources.

Key Dates

  • Call opens on: 24 June 2026
  • Call closes on: 16 September 2026
  • Call Information Session: 15 July 2026 – 13:30 – 14:30 CET – Register here
  • Open Q&A Session: 02 September 2026 – 11:00 CET – Register here

Where to find out more

Click here for the official call document and supporting documents

Call Updates:

  • Latest version: 6 July 2026

How to apply

  • Step 1: Register your organisation in the EU Funding & tender opportunities portal to obtain the nine‑digit Participant Identification Code (PIC number). If you do not know if your organisation already has a PIC number, you can verify directly on the EU Portal whether your organisation is already registered.
  • Step 2: Apply to the call via EIT Health’s application platform. Click on the "Apply" button below.
原始公告頁(部分政府網站禁止內嵌,空白時請點右側連結) ↗ 新分頁開啟

正規化數據

類型計劃徵求 ・ 開放中
出資方EIT Health
主辦/執行EIT Health
領域標籤生醫健康資通訊與AI
申請期間📅 2026-06-24 ~ 2026-09-16
公告日期(未取得)
經費

Between €300,000 and €500,000 EUR (EIT Health funding)

申請資格
  1. Private company, Micro, Small or Medium-sized enterprise (SME).
  2. At least 4 full‑time equivalent employees.
  3. Minimum total equity investment of 2,000,000 EUR within the previous 36 months, with at least one new investor.
  4. Innovation Maturity Level (IML) requirements:
    • Biotech: IML ≥ 5 (Safety/Toxicity study stage).
    • Medtech: IML ≥ 6 (Initial clinical PoC).
    • Digital: IML ≥ 7 (Market validation).
    • Biomarker/Diagnostics: IML ≥ 7.
摘要

EIT Health’s Transformative Healthcare Instrument provides €300,000‑€500,000 grants to high‑potential European start‑ups in biotech, medtech, digital health, AI, and biomarkers/diagnostics to advance product development, strengthen commercialisation and prepare for next fundraising while meeting unmet clinical needs across Europe.

入庫時間2026-08-19 16:54 ・ 最近重訪 2026-08-19 16:54

附件(0)

此專案沒有已確認內容的附件。
Ergon 為實驗性服務・回數據平台首頁・個別案件請以原始公告為準